Medication Reconciliation for Patients Over 65 Years Old : Cost Analysis of the Process Implemented in the Polyvalent Internal Medical Unit of Rennes University Hospital

NCT03670433 | Completed

• 1 other identifier: 35RC17_3081
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Among the strategies to secure the patient's care path, medication reconciliation is a powerful approach for the prevention and interception of medication errors.

Conditions

Medication Reconciliation

Keywords

Medication reconciliation; Care path; Prevention

Outcome Measures

Primary Outcomes (4)

• Time spent by professionals

  Evaluation of the time spent by each professionals involved in the completion of each step of the MR process.

  At the inclusion day

• Average cost of MR process

  Evaluation of average cost of MR process at UMIP. Only costs related to human resources are considered.

  At the inclusion day

• Number of unintentional discrepancies detected

  Number of unintentional discrepancies detected during MR at admission of patients at UMIP.

  At the inclusion day

• Severity of unintentional discrepancies detected

  Severity of unintentional discrepancies detected during MR at admission of patients at UMIP. Evaluation based on the algorithm provided by the HAS.

  At the inclusion day

Study Arms (1)

Patients admitted in the Polyvalent Internal Medical Unit

Patients over 65 years old admitted in the Polyvalent Internal Medical Unit (UMIP) of Rennes University Hospital between 09/04/2017 and 10/31/2017 or going back home or to a rehabilitation service during the same period. Cost analysis of medication reconciliation.

Other: Cost analysis of medication reconciliation

Interventions

Cost analysis of medication reconciliation OTHER

1. The MR at entry is performed by the pharmaceutical team as soon as possible after admission. The sequences of the medical conciliation are attributed to the health professionals according to the recommendations of the French National Authority for Health (HAS). 2. The MR at the discharge is carried out in collaboration between the pharmaceutical and medical teams. It associates the patient through pharmaceutical interview and relies on the sharing of informations related to the patient's medical treatments. These informations are synthesized in an output conciliation sheet transmitted in real time by secure messaging to the attending physician and the dispensing pharmacist. In parallel, the liaison letter and the patient discharge order are generated in order to guarantee a perfect homogeneity between all the documents transmitted at the patient's exit. MR sequences are attributed to health professionals according to the recommendations of the HAS.

Patients admitted in the Polyvalent Internal Medical Unit

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients over 65 years admitted at the UMIP of Rennes University Hospital between 09/04/2017 and 10/31/2017.

You may qualify if:

• Patients over 65 years old
• Patient non-institutionalized at entry
• For MR :
• Entry : patients admitted at UMIP between 09/04/2017 and 10/31/2017
• Discharge : patients returning home or going to a rehabilitation service between 04/09/2017 and 31/10/2017 and having received MR evaluation

You may not qualify if:

• Patients not returning home
• Refusal of participation
• Major persons subject to legal protection (safeguard of justice, guardianship), persons deprived of their liberty

Sponsors & Collaborators

• Rennes University Hospital: lead

Study Sites (1)

Rennes University Hospital

Rennes, 35000, France

Location

Study Officials

• Berengere CADOR, MD

  Rennes University Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 12, 2018
• First Posted: September 13, 2018
• Study Start: September 5, 2017
• Primary Completion: October 31, 2017
• Study Completion: October 31, 2017
• Last Updated: September 13, 2018

Record last verified: 2018-09

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)